Micro-X Limited
Micro-X Limited
Your view on MX1.AX
Overview
What the company does, where it operates, and who runs it.
About Micro-X Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Kingsley Campbell Hall
- Headquarters
- A14, 6 MAB Eastern Promenade, Tonsley, SA, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Kingsley Campbell Hall
- Headquarters
- A14, 6 MAB Eastern Promenade, Tonsley, SA, AU
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components.
It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions.
The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Micro-X Limited. Starting points for Micro-X Limited: EPS -AUD 0.01, beta -0.62 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Micro-X Limited. Micro-X Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Micro-X Limited. Trailing twelve-month EPS for Micro-X Limited stands at -AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJun 2016 | Next quarterJun 2017 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | −AUD 0.08 | −AUD 0.10 | −AUD 0.01 | −AUD 0.00 |
| Lowest estimate | −AUD 0.08 | −AUD 0.10 | −AUD 0.01 | −AUD 0.00 |
| Highest estimate | −AUD 0.07 | −AUD 0.09 | −AUD 0.01 | −AUD 0.00 |
| Number of analysts | 2 | 2 | 1 | 1 |
| A year ago | — | — | −AUD 0.011 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterJun 2016 | Next quarterJun 2017 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 507499.00 | AUD 3.53M | AUD 33.14M | AUD 39.24M |
| Lowest estimate | AUD 485000.00 | AUD 3.38M | AUD 33.14M | AUD 39.24M |
| Highest estimate | AUD 510000.00 | AUD 3.55M | AUD 33.14M | AUD 39.24M |
| Number of analysts | 2 | 2 | 1 | 1 |
| A year ago | — | — | AUD 15.09M | — |
| Growth vs a year ago | — | — | +119.7% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Micro-X Limited. Micro-X Limited has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ATX.AXAmplia Therapeutics Limited | Healthcare | Biotechnology | — | ||
| BMT.AXBeamtree Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| CMP.AXCompumedics Limited | Healthcare | Medical - Devices | — | ||
| CYC.AXCyclopharm Limited | Healthcare | Medical - Devices | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IPD.AXImpediMed Limited | Healthcare | Medical - Devices | — | ||
| M7T.AXMach7 Technologies Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| MVP.AXMedical Developments International Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| CNVIFConavi Medical Corp. | Healthcare | OTC | $20.7M | ||
| COCHEnvoy Medical, Inc. | Healthcare | NASDAQ | $52.1M | ||
| COCHWEnvoy Medical, Inc. | Healthcare | NASDAQ | $540,800 | ||
| COH.AXCochlear Limited | Healthcare | ASX | — | ||
| CRRVFCVR Medical Corp. | Healthcare | OTC | $1,072 | ||
| CSDXCS Diagnostics Corp. | Healthcare | OTC | $40.0M | ||
| CSSPFNIOX Group Plc | Healthcare | OTC | $384.5M | ||
| CSX.AXCleanSpace Holdings Limited | Healthcare | ASX | — | ||
| CTKBCytek Biosciences, Inc. | Healthcare | NASDAQ | $774.2M | ||
| CTSOCytosorbents Corporation | Healthcare | NASDAQ | $17.5M | ||
| CVCapsoVision, Inc. | Healthcare | NASDAQ | $365.6M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Micro-X Limited.